+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

EGFRm-positive NSCLC Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology, Product Type

  • PDF Icon

    Report

  • 89 Pages
  • January 2024
  • Region: Global
  • Prof Research
  • ID: 5922893
Description Jump to:
This report describes the global market size of EGFRm-positive NSCLC from 2019 to 2023 and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029.

For the geography segment, regional supply, demand, major players, price is presented from 2019 to 2029. This report cover following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For the competitor segment, the report includes global key players of EGFRm-positive NSCLC as well as some small players. The information for each competitor include:
  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share

Types Segment:

  • Afatinib
  • Amivantamab
  • Dacomitinib
  • Others

Companies Covered:

  • AstraZeneca
  • Johnson & Johnson
  • Takeda Pharmaceutical
  • Blueprint Medicines Corp
  • Dizal Pharmaceutical
  • Oric Pharmaceuticals
  • etc.
Base Year: 2024
Historical Data: from 2019 to 2023
Forecast Data: from 2024 to 2029


This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1 Executive SummaryChapter 2 Abbreviation and Acronyms
Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method
Chapter Four Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users
Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 COVID-19 Impact
Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Egfrm-Positive Nsclc Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users
Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics
Chapter 8 Historical and Forecast Egfrm-Positive Nsclc Market in North America (2019-2029)
8.1 Egfrm-Positive Nsclc Market Size
8.2 Egfrm-Positive Nsclc Market by End Use
8.3 Competition by Players/Suppliers
8.4 Egfrm-Positive Nsclc Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico
Chapter 9 Historical and Forecast Egfrm-Positive Nsclc Market in South America (2019-2029)
9.1 Egfrm-Positive Nsclc Market Size
9.2 Egfrm-Positive Nsclc Market by End Use
9.3 Competition by Players/Suppliers
9.4 Egfrm-Positive Nsclc Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru
Chapter 10 Historical and Forecast Egfrm-Positive Nsclc Market in Asia & Pacific (2019-2029)
10.1 Egfrm-Positive Nsclc Market Size
10.2 Egfrm-Positive Nsclc Market by End Use
10.3 Competition by Players/Suppliers
10.4 Egfrm-Positive Nsclc Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southeast Asia
10.5.6 Australia
Chapter 11 Historical and Forecast Egfrm-Positive Nsclc Market in Europe (2019-2029)
11.1 Egfrm-Positive Nsclc Market Size
11.2 Egfrm-Positive Nsclc Market by End Use
11.3 Competition by Players/Suppliers
11.4 Egfrm-Positive Nsclc Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia
Chapter 12 Historical and Forecast Egfrm-Positive Nsclc Market in MEA (2019-2029)
12.1 Egfrm-Positive Nsclc Market Size
12.2 Egfrm-Positive Nsclc Market by End Use
12.3 Competition by Players/Suppliers
12.4 Egfrm-Positive Nsclc Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey
Chapter 13 Summary For Global Egfrm-Positive Nsclc Market (2019-2024)
13.1 Egfrm-Positive Nsclc Market Size
13.2 Egfrm-Positive Nsclc Market by End Use
13.3 Competition by Players/Suppliers
13.4 Egfrm-Positive Nsclc Market Size by Type
Chapter 14 Global Egfrm-Positive Nsclc Market Forecast (2024-2029)
14.1 Egfrm-Positive Nsclc Market Size Forecast
14.2 Egfrm-Positive Nsclc Application Forecast
14.3 Competition by Players/Suppliers
14.4 Egfrm-Positive Nsclc Type Forecast
Chapter 15 Analysis of Global Key Vendors
15.1 AstraZeneca
15.1.1 Company Profile
15.1.2 Main Business and EGFRm-positive NSCLC Information
15.1.3 SWOT Analysis of AstraZeneca
215.1.4 AstraZeneca EGFRm-positive NSCLC Revenue, Gross Margin and Market Share (2019-2024)
15.2 Johnson & Johnson
15.2.1 Company Profile
15.2.2 Main Business and EGFRm-positive NSCLC Information
15.2.3 SWOT Analysis of Johnson & Johnson
215.2.4 Johnson & Johnson EGFRm-positive NSCLC Revenue, Gross Margin and Market Share (2019-2024)
15.3 Takeda Pharmaceutical
15.3.1 Company Profile
15.3.2 Main Business and EGFRm-positive NSCLC Information
15.3.3 SWOT Analysis of Takeda Pharmaceutical
215.3.4 Takeda Pharmaceutical EGFRm-positive NSCLC Revenue, Gross Margin and Market Share (2019-2024)
15.4 Blueprint Medicines Corp
15.4.1 Company Profile
15.4.2 Main Business and EGFRm-positive NSCLC Information
15.4.3 SWOT Analysis of Blueprint Medicines Corp
215.4.4 Blueprint Medicines Corp EGFRm-positive NSCLC Revenue, Gross Margin and Market Share (2019-2024)
15.5 Dizal Pharmaceutical
15.5.1 Company Profile
15.5.2 Main Business and EGFRm-positive NSCLC Information
15.5.3 SWOT Analysis of Dizal Pharmaceutical
215.5.4 Dizal Pharmaceutical EGFRm-positive NSCLC Revenue, Gross Margin and Market Share (2019-2024)
15.6 Oric Pharmaceuticals
15.6.1 Company Profile
15.6.2 Main Business and EGFRm-positive NSCLC Information
15.6.3 SWOT Analysis of Oric Pharmaceuticals
215.6.4 Oric Pharmaceuticals EGFRm-positive NSCLC Revenue, Gross Margin and Market Share (2019-2024)
List of Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Egfrm-Positive Nsclc Report
Table Data Sources of Egfrm-Positive Nsclc Report
Table Major Assumptions of Egfrm-Positive Nsclc Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Egfrm-Positive Nsclc Picture
Table Egfrm-Positive Nsclc Classification
Table Egfrm-Positive Nsclc Applications
Table Drivers of Egfrm-Positive Nsclc Market
Table Restraints of Egfrm-Positive Nsclc Market
Table Opportunities of Egfrm-Positive Nsclc Market
Table Threats of Egfrm-Positive Nsclc Market
Table COVID-19 Impact For Egfrm-Positive Nsclc Market
Table Raw Materials Suppliers
Table Different Production Methods of Egfrm-Positive Nsclc
Table Cost Structure Analysis of Egfrm-Positive Nsclc
Table Key End Users
Table Latest News of Egfrm-Positive Nsclc Market
Table Merger and Acquisition
Table Planned/Future Project of Egfrm-Positive Nsclc Market
Table Policy of Egfrm-Positive Nsclc Market
Table 2019-2029 North America Egfrm-Positive Nsclc Market Size
Figure 2019-2029 North America Egfrm-Positive Nsclc Market Size and CAGR
Table 2019-2029 North America Egfrm-Positive Nsclc Market Size by Application
Table 2019-2024 North America Egfrm-Positive Nsclc Key Players Revenue
Table 2019-2024 North America Egfrm-Positive Nsclc Key Players Market Share
Table 2019-2029 North America Egfrm-Positive Nsclc Market Size by Type
Table 2019-2029 United States Egfrm-Positive Nsclc Market Size
Table 2019-2029 Canada Egfrm-Positive Nsclc Market Size
Table 2019-2029 Mexico Egfrm-Positive Nsclc Market Size
Table 2019-2029 South America Egfrm-Positive Nsclc Market Size
Figure 2019-2029 South America Egfrm-Positive Nsclc Market Size and CAGR
Table 2019-2029 South America Egfrm-Positive Nsclc Market Size by Application
Table 2019-2024 South America Egfrm-Positive Nsclc Key Players Revenue
Table 2019-2024 South America Egfrm-Positive Nsclc Key Players Market Share
Table 2019-2029 South America Egfrm-Positive Nsclc Market Size by Type
Table 2019-2029 Brazil Egfrm-Positive Nsclc Market Size
Table 2019-2029 Argentina Egfrm-Positive Nsclc Market Size
Table 2019-2029 Chile Egfrm-Positive Nsclc Market Size
Table 2019-2029 Peru Egfrm-Positive Nsclc Market Size
Table 2019-2029 Asia & Pacific Egfrm-Positive Nsclc Market Size
Figure 2019-2029 Asia & Pacific Egfrm-Positive Nsclc Market Size and CAGR
Table 2019-2029 Asia & Pacific Egfrm-Positive Nsclc Market Size by Application
Table 2019-2024 Asia & Pacific Egfrm-Positive Nsclc Key Players Revenue
Table 2019-2024 Asia & Pacific Egfrm-Positive Nsclc Key Players Market Share
Table 2019-2029 Asia & Pacific Egfrm-Positive Nsclc Market Size by Type
Table 2019-2029 China Egfrm-Positive Nsclc Market Size
Table 2019-2029 India Egfrm-Positive Nsclc Market Size
Table 2019-2029 Japan Egfrm-Positive Nsclc Market Size
Table 2019-2029 South Korea Egfrm-Positive Nsclc Market Size
Table 2019-2029 Southeast Asia Egfrm-Positive Nsclc Market Size
Table 2019-2029 Australia Egfrm-Positive Nsclc Market Size
Table 2019-2029 Europe Egfrm-Positive Nsclc Market Size
Figure 2019-2029 Europe Egfrm-Positive Nsclc Market Size and CAGR
Table 2019-2029 Europe Egfrm-Positive Nsclc Market Size by Application
Table 2019-2024 Europe Egfrm-Positive Nsclc Key Players Revenue
Table 2019-2024 Europe Egfrm-Positive Nsclc Key Players Market Share
Table 2019-2029 Europe Egfrm-Positive Nsclc Market Size by Type
Table 2019-2029 Germany Egfrm-Positive Nsclc Market Size
Table 2019-2029 France Egfrm-Positive Nsclc Market Size
Table 2019-2029 United Kingdom Egfrm-Positive Nsclc Market Size
Table 2019-2029 Italy Egfrm-Positive Nsclc Market Size
Table 2019-2029 Spain Egfrm-Positive Nsclc Market Size
Table 2019-2029 Belgium Egfrm-Positive Nsclc Market Size
Table 2019-2029 Netherlands Egfrm-Positive Nsclc Market Size
Table 2019-2029 Austria Egfrm-Positive Nsclc Market Size
Table 2019-2029 Poland Egfrm-Positive Nsclc Market Size
Table 2019-2029 Russia Egfrm-Positive Nsclc Market Size
Table 2019-2029 MEA Egfrm-Positive Nsclc Market Size
Figure 2019-2029 MEA Egfrm-Positive Nsclc Market Size and CAGR
Table 2019-2029 MEA Egfrm-Positive Nsclc Market Size by Application
Table 2019-2024 MEA Egfrm-Positive Nsclc Key Players Revenue
Table 2019-2024 MEA Egfrm-Positive Nsclc Key Players Market Share
Table 2019-2029 MEA Egfrm-Positive Nsclc Market Size by Type
Table 2019-2029 Egypt Egfrm-Positive Nsclc Market Size
Table 2019-2029 Israel Egfrm-Positive Nsclc Market Size
Table 2019-2029 South Africa Egfrm-Positive Nsclc Market Size
Table 2019-2029 Gulf Cooperation Council Countries Egfrm-Positive Nsclc Market Size
Table 2019-2029 Turkey Egfrm-Positive Nsclc Market Size
Table 2019-2024 Global Egfrm-Positive Nsclc Market Size by Region
Table 2019-2024 Global Egfrm-Positive Nsclc Market Size Share by Region
Table 2019-2024 Global Egfrm-Positive Nsclc Market Size by Application
Table 2019-2024 Global Egfrm-Positive Nsclc Market Share by Application
Table 2019-2024 Global Egfrm-Positive Nsclc Key Vendors Revenue
Figure 2019-2024 Global Egfrm-Positive Nsclc Market Size and Growth Rate
Table 2019-2024 Global Egfrm-Positive Nsclc Key Vendors Market Share
Table 2019-2024 Global Egfrm-Positive Nsclc Market Size by Type
Table 2019-2024 Global Egfrm-Positive Nsclc Market Share by Type
Table 2024-2029 Global Egfrm-Positive Nsclc Market Size by Region
Table 2024-2029 Global Egfrm-Positive Nsclc Market Size Share by Region
Table 2024-2029 Global Egfrm-Positive Nsclc Market Size by Application
Table 2024-2029 Global Egfrm-Positive Nsclc Market Share by Application
Table 2024-2029 Global Egfrm-Positive Nsclc Key Vendors Revenue
Figure 2024-2029 Global Egfrm-Positive Nsclc Market Size and Growth Rate
Table 2024-2029 Global Egfrm-Positive Nsclc Key Vendors Market Share
Table 2024-2029 Global Egfrm-Positive Nsclc Market Size by Type
Table 2024-2029 Egfrm-Positive Nsclc Global Market Share by Type

Companies Mentioned

  • AstraZeneca
  • Johnson & Johnson
  • Takeda Pharmaceutical
  • Blueprint Medicines Corp
  • Dizal Pharmaceutical
  • Oric Pharmaceuticals
  • Black Diamond Therapeutics Inc.
  • Taiho Pharmaceutical Co. Ltd.
  • Boehringer Ingelheim
  • Bayer AG
  • ArriVent Biopharma

Related Topics

Related Reports

Anaplastic lymphoma kinase Non-Small Cell Lung Cancer (ALK-NSCLC) - Market Insight, Epidemiology and Market Forecast - 2034 - Product Image

Anaplastic lymphoma kinase Non-Small Cell Lung Cancer (ALK-NSCLC) - Market Insight, Epidemiology and Market Forecast - 2034

  • Report
  • 200 Pages
  • Global
From
HER2-mutant Non-Small Cell Lung Cancer - Pipeline Insight, 2024 - Product Image

HER2-mutant Non-Small Cell Lung Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • 60 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024 - Product Image

Non-Small Cell Lung Cancer (NSCLC) Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029 - Product Image

Non-Small Cell Lung Cancer (NSCLC) - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts 2019 - 2029

  • Report
  • 110 Pages
  • Global
From
Non-Small Cell Lung Cancer (NSCLC) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034 - Product Image

Non-Small Cell Lung Cancer (NSCLC) Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2034

  • Report
  • 130 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.